Association between Hepatitis B Virus X Gene Mutations and Clinical Status in Patients with Chronic Hepatitis B

Eun Young Cho1, Chang Soo Choi, Ji-Hyun Cho

  • 1Department of Internal Medicine, Wonkwang University Hospital, Wonkwang University College of Medicine, Iksan, Korea.

Gut and Liver
|April 5, 2011
PubMed

Insights

Specific mutations in the hepatitis B virus (HBV) X gene are linked to disease progression in patients with chronic HBV infection. These HBV X gene mutations correlate with clinical status, including cirrhosis and hepatocellular carcinoma (HCC).

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Hepatitis B virus (HBV) infection is a global health concern.
  • The HBV X gene plays a crucial role in viral replication and pathogenesis.
  • Limited data exists on the association between entire HBV X gene mutations and clinical outcomes.

Purpose of the Study:

  • To investigate the association between mutations in the complete HBV X gene and the clinical status of HBV genotype C infected patients.
  • To compare the prevalence of X gene mutations across different stages of chronic HBV infection: chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC).

Main Methods:

  • Direct sequencing was used to analyze HBV X genes from 194 patients.
  • The study population included patients with chronic hepatitis (n=60), liver cirrhosis (n=65), and HCC (n=69).
  • Sequencing results were compared among the three clinical groups.

Main Results:

  • Several HBV X gene mutations (G1386M, C1485T, C1653T, T1753V, A1762T, G1764A) showed significant associations with clinical status.
  • Mutations T1753V and A1762T/G1764A were more frequent in Hepatitis B e antigen (HBeAg)-negative patients.
  • Specific mutations (G1386M, C1653T, A1762T/G1764A) were more prevalent in cirrhosis and HCC patients compared to chronic hepatitis patients.
  • The T1753V mutation showed a significant increase in prevalence with disease progression from cirrhosis to HCC.

Conclusions:

  • Distinct patterns of HBV X gene mutations are associated with varying clinical statuses in chronic HBV infection.
  • These findings highlight the potential role of specific X gene mutations as biomarkers for HBV disease progression.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...